◆英語タイトル:Kadimastem Ltd (KDST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8246
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenitors derived from human pluripotent stem cells (hPSCs) thus having potential applications for diabetes, and for neurodegenerative diseases such as ALS. The company has developed a groundbreaking process to differentiate the cells in the lab, unlike other technologies which transplant immature precursor cells. Kadimastem’s regenerative medicine program is designed to allow large-scale production of encapsulated devices which is implanted in patients sensing blood glucose levels and secret insulin. The company provides drug discovery and development services. Kadimastem is headquartered in Ness Ziona, Israel.
Kadimastem Ltd (KDST) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kadimastem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kadimastem Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kadimastem to Enter into Agreement with Corestem 11
Kadimastem to Enter into Agreement with Hadasit Medical Research Services & Development 12
Kadimastem Enters into Research Agreement with Ramot at Tel Aviv University 13
Equity Offering 14
Kadimastem Raises USD5.2 Million in Private Placement of Shares 14
Kadimastem Raises USD4.4 Million in Rights Offering Of Shares 15
Kadimastem Raises USD0.9 Million in Private Placement of Shares 16
Kadimastem Raises USD1.9 Million in Rights Offering of Shares 17
Kadimastem Raises USD1 Million in Public Offering of Shares 18
Kadimastem Completes IPO For US$5.6 Million 19
Kadimastem Ltd – Key Competitors 21
Kadimastem Ltd – Key Employees 22
Kadimastem Ltd – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Corporate Communications 24
Apr 02, 2018: Prof. Joseph Itskovitz-Eldor, a World Leader in the Field of Stem Cells Joins Kadimastems Board of Directors 24
Legal and Regulatory 25
Jun 05, 2017: 2017 Innovation Authority Budget Approved for Kadimastem: NIS 12 M for ALS Project 25
Government and Public Interest 26
Jul 02, 2018: Kadimastem and The Australian Foundation for Diabetes Research (AFDR) Selected to Receive a Bi-National Grant from the Australian Government and the Israel Innovation Authority to Explore a Combined Diabetes Solution 26
Aug 24, 2017: Kadimastem to Receive Additional Grant from the EU’s Prestigious R&D Program 27
Product News 28
06/21/2017: Kadimastem Received Approval from the Hadassah Hospital IRB (Helsinki Committee) for Conducting a Clinical Trial in ALS Patients 28
04/26/2018: Kadimastem Announces the Enrollment of the First Patient for Its Clinical Trial in ALS Patients 29
03/13/2018: New Hope for ALS Patients Worldwide 30
Clinical Trials 31
Jun 06, 2018: Scientific Article by Kadimastem Regarding Its Cell-Based Treatment for ALS Published by a Prestigious Cell Therapy Scientific Journal 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Kadimastem Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kadimastem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kadimastem Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Kadimastem Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kadimastem to Enter into Agreement with Corestem 11
Kadimastem to Enter into Agreement with Hadasit Medical Research Services & Development 12
Kadimastem Enters into Research Agreement with Ramot at Tel Aviv University 13
Kadimastem Raises USD5.2 Million in Private Placement of Shares 14
Kadimastem Raises USD4.4 Million in Rights Offering Of Shares 15
Kadimastem Raises USD0.9 Million in Private Placement of Shares 16
Kadimastem Raises USD1.9 Million in Rights Offering of Shares 17
Kadimastem Raises USD1 Million in Public Offering of Shares 18
Kadimastem Completes IPO For US$5.6 Million 19
Kadimastem Ltd, Key Competitors 21
Kadimastem Ltd, Key Employees 22
List of Figures
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kadimastem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kadimastem Ltd, Medical Devices Deals, 2012 to YTD 2018 9